<DOC>
	<DOCNO>NCT01665469</DOCNO>
	<brief_summary>Consumption high-fat meal result postprandial ( fed-state ) response characterize hypertriglyceridemia . Postprandial hypertriglyceridemia increase oxidation low-density lipoprotein ( LDL ) increase blood concentration several biomarkers inﬂammation . This postprandial lipemia-induced oxidative stress mediate response high-fat meal suggest major contributor pathogenesis atherosclerosis along chronic disease state diabetes obesity . Consumption food rich antioxidant compound provide defence source compliment endogenous defence system protect oxidative damage pro-oxidant condition . The hypothesis study tomato extract lycopene able decrease postprandial oxidation inﬂammation healthy weight men woman compare Placebo .</brief_summary>
	<brief_title>Effect Tomato Extracted Lycopene Postprandial Oxidation inﬂammation Healthy Weight Men Women</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Lycopene</mesh_term>
	<mesh_term>Carotenoids</mesh_term>
	<criteria>1 . Male female 2 . Age : 21 70 year inclusive 3 . Subject Body Mass Index : 19 25 kg/m2 inclusive 4 . Subject Fasting serum LDLcholesterol : ≥ 100 mg/dL &lt; 200 mg/dL 5 . Subject Highsensitivity Creactive protein ( hsCRP ) &lt; 1.0 mg/L 6 . Subject willing take supplement daily 4 week undergo studyrelated procedure 7 . Subject otherwise general good health determine principal investigator 8 . Subjects willing sign inform consent form prior join study 1 . Subjects suffer overweight define BMI &gt; 25 kg/m2 2 . Subject actively lose weight ( e.g . diet ) subject great 5 % change body weight within 1 month prior randomization visit 3 . Subject take lipidaltering drug therapy within six week prior screen . Also exclude supplement know significant lipid alter effect , niacin , garlic , omega3 fatty acid , red yeast rice extract , phytostanols / phytosterols , soluble fiber , chitosan conjugate linoleic acid 4 . Subjects use follow medication : systemic corticosteroid , orlistat , bile acid resin , prescription omega3 fatty acid , cyclical noncontinuous hormone therapy 5 . Subjects use antioxidant agent vitamin within 6 week prior inclusion study . For subject use vitamin supplementation 6 week wash require prior inclusion study . 6 . Subjects able follow dietary proscription screen visit final visit 7 . Subjects follow special diet include , limited liquid , high low protein , raw food , vegetarian vegan , etc . 8 . Subjects know allergy tomato , carotenoid , vitamin E 9 . Subjects smoke ( past smoker allow smoke cease &gt; 2 year prior study inclusion ) 10 . Subjects high fast serum triglyceride 11 . Subjects diagnosis type 1 type 2 diabetes mellitus 12 . Subjects high serum thyroidstimulating hormone 13 . Subjects aspartate aminotransferase ( AST ) alanine transaminase ( ALT ) &gt; 3 time upper limit normal 14 . Subjects Creatinine ≥ 1.5 mg/dl 15 . Subjects highsensitivity Creactive protein 16 . Woman subject positive pregnancy test 17 . Woman subject breast feeding , pregnant , plan become pregnant duration study 18 . Subjects know cardiovascular disease stroke , except condition deem clinically insignificant Principle Investigator Subinvestigator , study site physician ( e.g . clinically insignificant atherosclerotic lesion observe image study ) . 19 . Subject history significant gastrointestinal disease severe constipation , diarrhea , malabsorptive disease , inflammatory bowel disease ( e.g . Crohn 's disease , ulcerative colitis ) 20 . Subject history severe psychiatric illness opinion investigator would interfere optimal participation study 21 . Subject history bariatric surgery 22 . Subject history current use illegal `` recreational '' drug 23 . Subject use investigational drug ( ) 60 day prior screen 24 . Subject participate clinical trial participate trial</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>anti oxidation</keyword>
	<keyword>lycopene</keyword>
	<keyword>Ox-LDL</keyword>
</DOC>